Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Phosphodiesterase Inhibitors in Patients With Group 2 Pulmonary Hypertension

NCT06350773 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT06350773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06350773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Phosphodiesterase Inhibitors in Patients With Group 2 Pulmonary Hypertension
Lead sponsor
Beni-Suef University
Phase
Not applicable
Overall status
Completed
Start date
March 10, 2023
Completion date
October 25, 2025
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cpcph, group 2 pulmonary hypertension